drugset / Trial / NCT02563288

Esmolol Versus Dexmedetomidine During Intracranial Procedures

NCT02563288

Phase 3 Unknown 60 enrolled George Papanicolaou Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Patients undergoing intracranial procedures may experience severe hypertension and tachycardia due to intracranial hypertension and to increased release of adrenaline. Preventing perioperative sympathetic activity is of great importance. A common technique is using b-blockers like esmolol, which effectively block perioperative hemodynamic changes during intracranial surgery. A2 agonists, like Dexmedetomidine-Dex are now being used as a component of a balanced anesthesia during neurosurgical procedures. This study aimed to evaluate whether esmolol or dex attenuates perioperative changes in patients undergoing elective craniotomy with fast track neuroanesthesia.

Timeline

Start
2016-08
Primary completion
2017-08
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.7 ug/kg
Comparator Esmolol Other / unclassified 0.3 mg/kg